FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322772364> ?p ?o ?g. }

• W4322772364 endingPage "9" @default.
• W4322772364 startingPage "1" @default.
• W4322772364 abstract "An Italian real-world retrospective study was conducted in patients with psoriasis (PSO) to evaluate their characteristics, treatment patterns, and biological/targeted synthetic disease-modifying antirheumatic drug (b/tsDMARD) drug utilization.The retrospective analysis was carried out on real-world data collected from administrative databases of selected Italian health-departments; the dataset covered approximately 22% of the Italian population. PSO patients (identified by PSO hospitalization, and/or active exemption code and/or a topical anti-psoriatic medication prescription) were included. In prevalent patients identified during 2017-2018-2019-2020, baseline characteristics and treatment patterns were investigated. Moreover, b/tsDMARD drug utilization (focusing on persistence, monthly dosage, and mean duration between prescriptions) was evaluated in bionaïve patients included during 2015 and 2018.PSO was diagnosed in 241,552 (in 2017), 269,856 (in 2018), 293,905 (in 2019) and 301,639 (in 2020) patients. At the index date, almost 50% of patients had not received systemic medications, and 2% had received biological treatment. Among the b/tsDMARD-treated patients, a decrease in the use of tumour necrosis factor (TNF) inhibitors (60.0-36.4%, from 2017 to 2020) and an increase in the use of interleukin (IL) inhibitors (36.3-50.6%, from 2017 to 2020) were observed. In 2018, the persistence rates of TNF inhibitors and IL inhibitors in bionaïve patients ranged from 60.8-79.7% and 83.3-87.9%, respectively.This real-world study of PSO drug utilization in Italy showed that a significant number of patients were not treated with systemic medications and only 2% of patients were treated with biologics. An increase in the use of IL inhibitors and a decrease in the prescription of TNF inhibitors over years were found. Patients treated with biologics were highly persistent with treatment. These data provide insight into routine clinical practice for PSO patients in Italy, suggesting that the optimization of treatment for PSO still represents an unmet medical need." @default.
• W4322772364 created "2023-03-03" @default.
• W4322772364 creator A5003801571 @default.
• W4322772364 creator A5042358274 @default.
• W4322772364 creator A5045529641 @default.
• W4322772364 creator A5053214629 @default.
• W4322772364 creator A5056888591 @default.
• W4322772364 creator A5069480320 @default.
• W4322772364 creator A5080020655 @default.
• W4322772364 date "2023-03-01" @default.
• W4322772364 modified "2023-09-25" @default.
• W4322772364 title "Analysis of Drug Utilization in Patients with Psoriasis: A Real-World Retrospective Study Among the Italian Population" @default.
• W4322772364 cites W1957267795 @default.
• W4322772364 cites W1958691323 @default.
• W4322772364 cites W1973354423 @default.
• W4322772364 cites W1977695408 @default.
• W4322772364 cites W1980567384 @default.
• W4322772364 cites W2051726326 @default.
• W4322772364 cites W2071065611 @default.
• W4322772364 cites W2073501077 @default.
• W4322772364 cites W2088804269 @default.
• W4322772364 cites W2134835251 @default.
• W4322772364 cites W2149224762 @default.
• W4322772364 cites W2154960154 @default.
• W4322772364 cites W2157118376 @default.
• W4322772364 cites W2158411099 @default.
• W4322772364 cites W2167606334 @default.
• W4322772364 cites W2171889601 @default.
• W4322772364 cites W2516755733 @default.
• W4322772364 cites W2541138259 @default.
• W4322772364 cites W2576647440 @default.
• W4322772364 cites W2593291425 @default.
• W4322772364 cites W2620306249 @default.
• W4322772364 cites W2805605213 @default.
• W4322772364 cites W2811213036 @default.
• W4322772364 cites W2912058252 @default.
• W4322772364 cites W2924895007 @default.
• W4322772364 cites W2988218726 @default.
• W4322772364 cites W2996422894 @default.
• W4322772364 cites W3023068416 @default.
• W4322772364 cites W3025236502 @default.
• W4322772364 cites W3045108962 @default.
• W4322772364 cites W3126106680 @default.
• W4322772364 cites W3132245798 @default.
• W4322772364 cites W3190377176 @default.
• W4322772364 cites W3206039614 @default.
• W4322772364 cites W3207458298 @default.
• W4322772364 cites W4210980790 @default.
• W4322772364 cites W4230599959 @default.
• W4322772364 cites W4281795623 @default.
• W4322772364 doi "https://doi.org/10.2147/ptt.s396003" @default.
• W4322772364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36891082" @default.
• W4322772364 hasPublicationYear "2023" @default.
• W4322772364 type Work @default.
• W4322772364 citedByCount "1" @default.
• W4322772364 countsByYear W43227723642023 @default.
• W4322772364 crossrefType "journal-article" @default.
• W4322772364 hasAuthorship W4322772364A5003801571 @default.
• W4322772364 hasAuthorship W4322772364A5042358274 @default.
• W4322772364 hasAuthorship W4322772364A5045529641 @default.
• W4322772364 hasAuthorship W4322772364A5053214629 @default.
• W4322772364 hasAuthorship W4322772364A5056888591 @default.
• W4322772364 hasAuthorship W4322772364A5069480320 @default.
• W4322772364 hasAuthorship W4322772364A5080020655 @default.
• W4322772364 hasBestOaLocation W43227723641 @default.
• W4322772364 hasConcept C126322002 @default.
• W4322772364 hasConcept C167135981 @default.
• W4322772364 hasConcept C203014093 @default.
• W4322772364 hasConcept C2426938 @default.
• W4322772364 hasConcept C2780035454 @default.
• W4322772364 hasConcept C2780564577 @default.
• W4322772364 hasConcept C2908647359 @default.
• W4322772364 hasConcept C71924100 @default.
• W4322772364 hasConcept C98274493 @default.
• W4322772364 hasConcept C99454951 @default.
• W4322772364 hasConceptScore W4322772364C126322002 @default.
• W4322772364 hasConceptScore W4322772364C167135981 @default.
• W4322772364 hasConceptScore W4322772364C203014093 @default.
• W4322772364 hasConceptScore W4322772364C2426938 @default.
• W4322772364 hasConceptScore W4322772364C2780035454 @default.
• W4322772364 hasConceptScore W4322772364C2780564577 @default.
• W4322772364 hasConceptScore W4322772364C2908647359 @default.
• W4322772364 hasConceptScore W4322772364C71924100 @default.
• W4322772364 hasConceptScore W4322772364C98274493 @default.
• W4322772364 hasConceptScore W4322772364C99454951 @default.
• W4322772364 hasLocation W43227723641 @default.
• W4322772364 hasLocation W43227723642 @default.
• W4322772364 hasLocation W43227723643 @default.
• W4322772364 hasOpenAccess W4322772364 @default.
• W4322772364 hasPrimaryLocation W43227723641 @default.
• W4322772364 hasRelatedWork W2093455167 @default.
• W4322772364 hasRelatedWork W2229283223 @default.
• W4322772364 hasRelatedWork W2741389566 @default.
• W4322772364 hasRelatedWork W2800611592 @default.
• W4322772364 hasRelatedWork W2989865808 @default.
• W4322772364 hasRelatedWork W3003365 @default.
• W4322772364 hasRelatedWork W3013145321 @default.
• W4322772364 hasRelatedWork W3089170113 @default.

• next